EWTX - Edgewise Therapeutics, Inc.

Over the past 90 days, insiders at Edgewise Therapeutics, Inc. (EWTX) have been net sellers, shedding 43,429 shares worth roughly $1.9M on balance.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kevin Koch	52.5K	$1.98M	-
Other	Behrad Derakhshan	31.8K	$1.20M	-
Other	Alan J Russell	31.5K	$1.19M	-
Dir	Jonathan C Fox	25.1K	$947.3K	-
Dir	Badreddin Edris	19.8K	$746.8K	-

Buys and sells only

10 filings · page 6

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 23, 2024	Peter A. Thompson64	Director, 10% Owner	Buy	454,545	$11.00	$4,999,995.00	+3.3%	-2.5%	+75.5%
Jan 23, 2024	Orbimed Advisors LLC68	Director, 10% Owner	Buy	454,545	$11.00	$4,999,995.00	+3.3%	-2.5%	+75.5%
Dec 27, 2023	John R Moore	General Counsel	Sell	8,497	$10.50	$89,218.50	-100%	+41.7%	+145.1%
Dec 26, 2023	Alan J Russell74	Chief Scientific Officer	Sell	172,585	$9.33	$1,610,097.24	-98.0%	+68.1%	+211.6%
Dec 26, 2023	Jonathan C Fox	Director	Buy	10,857	$9.30	$100,958.16	New	+68.1%	+211.6%
May 2, 2023	Behrad Derakhshan50	Chief Business Officer	Sale+OE	1,747	$8.90	$15,556.86	-19.9%	-16.7%	+117.3%
May 2, 2023	John R Moore	General Counsel	Sale+OE	1,897	$8.90	$16,892.60	-22.4%	-16.7%	+117.3%
May 2, 2023	R Michael Carruthers46	Chief Financial Officer	Sale+OE	1,336	$8.90	$11,896.95	-7.7%	-16.7%	+117.3%
May 2, 2023	Alan J Russell74	Chief Scientific Officer	Sale+OE	1,602	$8.90	$14,265.65	-0.9%	-16.7%	+117.3%
May 2, 2023	Joanne M. Donovan49	CMO	Sale+OE	3,254	$8.90	$28,976.54	-24.6%	-16.7%	+117.3%